444 related articles for article (PubMed ID: 21959353)
1. Optimising growth in phenylketonuria: current state of the clinical evidence base.
Dokoupil K; Gokmen-Ozel H; Lammardo AM; Motzfeldt K; Robert M; Rocha JC; van Rijn M; Ahring K; Bélanger-Quintana A; MacDonald A
Clin Nutr; 2012 Feb; 31(1):16-21. PubMed ID: 21959353
[TBL] [Abstract][Full Text] [Related]
2. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
[TBL] [Abstract][Full Text] [Related]
3. Unrestricted consumption of fruits and vegetables in phenylketonuria: no major impact on metabolic control.
Rohde C; Mütze U; Weigel JF; Ceglarek U; Thiery J; Kiess W; Beblo S
Eur J Clin Nutr; 2012 May; 66(5):633-8. PubMed ID: 22318648
[TBL] [Abstract][Full Text] [Related]
4. A survey of natural protein intake in Dutch phenylketonuria patients: insight into estimation or measurement of dietary intake.
van Rijn M; Jansma J; Brinksma A; Bakker HD; Boers GH; Carbasius-Weber E; Douwes AC; van den Herberg A; Ter Horst NM; de Klerk JB; de Koning TJ; van den Ploeg L; Rubio-Gozalbo ME; Sels JP; Sengers RC; de Valk HW; Termeulen H; Zweers H; van Spronsen FJ
J Am Diet Assoc; 2008 Oct; 108(10):1704-7. PubMed ID: 18926138
[TBL] [Abstract][Full Text] [Related]
5. Dietary management practices in phenylketonuria across European centres.
Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
Clin Nutr; 2009 Jun; 28(3):231-6. PubMed ID: 19362397
[TBL] [Abstract][Full Text] [Related]
6. The relationship between dietary intake, growth and body composition in Phenylketonuria.
Evans M; Truby H; Boneh A
Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
[TBL] [Abstract][Full Text] [Related]
7. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
8. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
[TBL] [Abstract][Full Text] [Related]
9. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
Gropper SS; Yannicelli S; White BD; Medeiros DM
Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
[TBL] [Abstract][Full Text] [Related]
11. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients.
Sitta A; Manfredini V; Biasi L; Treméa R; Schwartz IV; Wajner M; Vargas CR
Mutat Res; 2009; 679(1-2):13-6. PubMed ID: 19665577
[TBL] [Abstract][Full Text] [Related]
12. Changing dietary practices in phenylketonuria.
MacDonald A; Gökmen-Ozel H; Daly A
Turk J Pediatr; 2009; 51(5):409-15. PubMed ID: 20112594
[TBL] [Abstract][Full Text] [Related]
13. Weaning infants with phenylketonuria: a review.
MacDonald A; Evans S; Cochrane B; Wildgoose J
J Hum Nutr Diet; 2012 Apr; 25(2):103-10. PubMed ID: 21819461
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
[TBL] [Abstract][Full Text] [Related]
15. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres.
Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen-Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M
Eur J Clin Nutr; 2011 Feb; 65(2):275-8. PubMed ID: 21119696
[TBL] [Abstract][Full Text] [Related]
16. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
[TBL] [Abstract][Full Text] [Related]
17. The time has come: a new scene for PKU treatment.
Santos LL; Magalhães Mde C; Januário JN; Aguiar MJ; Carvalho MR
Genet Mol Res; 2006 Mar; 5(1):33-44. PubMed ID: 16755495
[TBL] [Abstract][Full Text] [Related]
18. Adult patients with well-controlled phenylketonuria tolerate incidental additional intake of phenylalanine.
van Rijn M; Hoeksma M; Sauer PJ; Modderman P; Reijngoud DJ; van Spronsen FJ
Ann Nutr Metab; 2011; 58(2):94-100. PubMed ID: 21474926
[TBL] [Abstract][Full Text] [Related]
19. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
[TBL] [Abstract][Full Text] [Related]
20. Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.
Martynyuk AE; Ucar DA; Yang DD; Norman WM; Carney PR; Dennis DM; Laipis PJ
Epilepsia; 2007 Jun; 48(6):1143-50. PubMed ID: 17484755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
